Zai Lab (ZLAB) Gains from Investment Securities (2020 - 2026)
Zai Lab's (ZLAB) quarterly Gains from Investment Securities came in at $78000.0 in Q1 2026, up 105.57% year-on-year from $37943.8 in Q1 2025, and up 114.39% quarter-over-quarter from -$542000.0 in Q4 2025.
Zai Lab (ZLAB) Gains from Investment Securities (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Gains from Investment Securities across 7 years of filings, most recently posting $78000.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $78000.0, up 105.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $937000.0 (up 144.09% YoY), and the FY2025 annual result was -$542000.0, down 19.65% from the prior year.
- Gains from Investment Securities came in at $78000.0 for Q1 2026 at Zai Lab, up from -$542000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $7.2 million in Q2 2023 to a low of -$8.9 million in Q4 2023.
- The 5-year median for Gains from Investment Securities is $51000.0 (2025), against an average of -$97882.4.
- Peak annual rise in Gains from Investment Securities reached 115000.0% in 2022, while the deepest fall reached 10566.67% in 2022.
- Zai Lab's Gains from Investment Securities stood at -$7.7 million in 2022, then slipped by 15.28% to -$8.9 million in 2023, then soared by 50.65% to -$4.4 million in 2024, then jumped by 87.68% to -$542000.0 in 2025, then jumped by 114.39% to $78000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $78000.0 (Q1 2026), -$542000.0 (Q4 2025), and $51000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | -542,000.00 |
| Dec 31, 2025 | -542,000.00 |
| Sep 30, 2025 | 51,000.00 |
| Sep 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | -1.40 Mn |
| Mar 31, 2025 | -1.40 Mn |
| Dec 31, 2024 | -4.40 Mn |
| Dec 31, 2024 | -4.40 Mn |
| Sep 30, 2024 | 3.71 Mn |
| Sep 30, 2024 | 3.71 Mn |
| Jun 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Mar 31, 2024 | 271,000.00 |
| Mar 31, 2024 | 271,000.00 |
| Dec 31, 2023 | -8.91 Mn |
| Dec 31, 2023 | -8.91 Mn |